Tesla is slated to report first-quarter delivery figures on Thursday. Shares of the electric-vehicle maker were up 1.4% at $376.76 in premarket trading Wednesday, while and futures were both up about 0.5%. Wall Street is expecting about 366,000 vehicles sold in the first quarter, up from 337,000 a year ago.
Tesla is slated to report first-quarter delivery figures on Thursday. Shares of the electric-vehicle maker were up 1.4% at $376.76 in premarket trading Wednesday, while and futures were both up about 0.5%. Wall Street is expecting about 366,000 vehicles sold in the first quarter, up from 337,000 a year ago.
aprott/iStock via Getty Images Novo Nordisk’s ( NVO ) GLP-1 drug Wegovy (semaglutide) will reach a larger base of patients in the UK with new recommendations from the National Institute for Health and Care Excellence. NICE has recommended the injectable drug to over 1M people to prevent stroke and heart attack, particularly those who have an elevated risk or circulation issues in the leg, and over...
aprott/iStock via Getty Images Novo Nordisk’s ( NVO ) GLP-1 drug Wegovy (semaglutide) will reach a larger base of patients in the UK with new recommendations from the National Institute for Health and Care Excellence. NICE has recommended the injectable drug to over 1M people to prevent stroke and heart attack, particularly those who have an elevated risk or circulation issues in the leg, and overweight patients. The medication, popular for weight loss, will be offered above current drugs being offered to the patient population, including statins. NICE noted that clinical trial data showed Wegovy was linked to a lower risk of heart attack, stroke or cardiovascular death, and the benefit was seen even before significant weight loss occured. The new recommendations cover adults who previously suffered a heart attack or stroke, or have peripheral arterial disease or a body mass index of at least 27. “Around 1.2 million people could use semaglutide to help protect them against having further heart attacks or strokes as the medicine is made available for this condition,” the statement added. “We know that people who have already had a heart attack or stroke are living with real fear that it could happen again. Today's decision gives thousands of people in that situation an extra layer of protection, on top of the medicines they are already taking,” NICE said in its statement on 1 April. More on Novo Nordisk A/S Novo Nordisk: Why I Still Find It An Interesting Opportunity Novo Nordisk: A Comeback Story In The World's Fastest-Growing Drug Market Novo Nordisk A/S (NOVO:CA) Shareholder/Analyst Call Transcript Novo’s China obesity drug posts positive mid-stage trial results Novo Nordisk board proposes DKK 7.95 final dividend for 2025, initiates DKK 15B buyback
Sergio Delle Vedove Nike ( NKE ) is on the radar of analysts and investors after reporting a year-over-year decline in profit and issuing guidance below expectations. The report is being seen as an indication of an uneven recovery for the athletic apparel giant. RBC Capital Markets analyst Piral Dadhania said the firm remains constructive on Nike's ( NKE ) mid-term recovery potential. However, the...
Sergio Delle Vedove Nike ( NKE ) is on the radar of analysts and investors after reporting a year-over-year decline in profit and issuing guidance below expectations. The report is being seen as an indication of an uneven recovery for the athletic apparel giant. RBC Capital Markets analyst Piral Dadhania said the firm remains constructive on Nike's ( NKE ) mid-term recovery potential. However, the shape of recovery is now seen as taking longer than initially anticipated, largely due to the Greater China, Converse, and sportswear drags. On the positive side, Dadhania said Nike ( NKE ) management appears willing to take hard decisions to address shortcomings and reset the business for longer-term sustainable growth, with the Win Now playbook considered as the right strategy. RBC Capital lowered its price target on Nike ( NKE ) to $70 while maintaining an Outperform rating. BTIG clipped its price target on Nike ( NKE ) to $75 as it pointed to a recovery taking longer than anticipated. Analyst Robert Drbul and his team are still confident about the long-term trajectory for the Buy-rated stock. "Margins are expected to inflect positively for the company in 2Q27, as the company laps tariff pressures. We continue to see significant margin recovery opportunitiesin FY27 and into FY28, with its target of DD operating margins, which leads to EPS potential over $3," updated Drbul. Needham was more cautious on the setup for Nike ( NKE ). "While some of the key aspects of the Win Now strategy make sense (refocus on sport, wholesale, marketing, etc.), the external environment is highly challenging, and the prior CEO may have dug the company into a bigger hole than it seemed," warned analyst Tom Nikic. Needham has a Hold rating on Nike ( NKE ). Bank of America downgraded Nike ( NKE ) to a Neutral rating after having it set at Buy. "Strong results in running and North America were the reasons for our patience, but with the sales inflection now nine months away, we see little room fo...
Valmont (VMI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Valmont (VMI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BigBear.ai (NYSE: BBAI) looks like a failed AI stock, but that may provide for a perfect entry point. A stronger balance sheet, a massive backlog, and a possible new catalyst could just be enough to send the stock soaring once again. Stock prices used were the market prices of March 23, 2026. The video was published on March 27, 2026. Continue reading
BigBear.ai (NYSE: BBAI) looks like a failed AI stock, but that may provide for a perfect entry point. A stronger balance sheet, a massive backlog, and a possible new catalyst could just be enough to send the stock soaring once again. Stock prices used were the market prices of March 23, 2026. The video was published on March 27, 2026. Continue reading
Trump is set to address the nation after saying the U.S. will withdraw from Iran in 2-3 weeks. And, the president will be at the Supreme Court today as arguments on birthright citizenship begin. (Image credit: Brendan Smialowski)
Trump is set to address the nation after saying the U.S. will withdraw from Iran in 2-3 weeks. And, the president will be at the Supreme Court today as arguments on birthright citizenship begin. (Image credit: Brendan Smialowski)
MicroStockHub/iStock via Getty Images Introduction So far, the first three months or so in 2026 have seen market volatility increase due to a number of factors. Particularly, the war with Iran has resulted in economic uncertainty. And going forward, I think this will continue unless we come to an agreement. If we don't, then I believe it's likely we'll continue to see market volatility, recession ...
MicroStockHub/iStock via Getty Images Introduction So far, the first three months or so in 2026 have seen market volatility increase due to a number of factors. Particularly, the war with Iran has resulted in economic uncertainty. And going forward, I think this will continue unless we come to an agreement. If we don't, then I believe it's likely we'll continue to see market volatility, recession odds increase, or the potential to see stagflation. However, this makes income investing even more attractive. Especially in stocks backed by strong fundamentals with higher yields and the likelihood to continue rewarding shareholders with reliable income. In this article, I discuss two attractively priced stocks that are likely to do just that for the foreseeable future. Knowing When To Buy As someone who's been investing for some time now, buying quality stocks isn't all that difficult. To me, the most difficult part about investing is knowing when to buy those quality stocks. Buying stocks when everyone else is interested is a way to either underperform or see muted portfolio returns. Basically, it's best to buy when others are fearful, like now. As previously mentioned, the war with Iran has investors spooked. According to the CNN Fear & Greed Index, the market is experiencing extreme fear at the moment. CNN Fear & Greed Index As a result, the overall market has experienced increased volatility through the first three months plus. This is after closing up over 16% in 2025. So far, all the momentum has been lost. And until we see more clarity around the war, I believe this will continue. But in my opinion, now is the best time to be a dividend investor. Especially if you can buy stocks with yields above the rate of inflation with the likelihood to continue growing them. The two in this article are attractively priced with well-covered dividends. And both have solid dividend yields. Without further ado, let's get into them. Omnicom Group ( OMC ) - Fwd Yield 4.33% At the c...
The "Good News" Is Always The Same: The Stock Market Is Up... Until It Isn't Authored by Charles Hugh Smith via OfTwoMinds blog, Cloaking a fake "market" with artifice to maintain its asymmetrical distribution of wealth and income also cloaks its detachment from the real world. I often refer to the dynamics of self-correction and self-liquidation. Systems that use feedback to rebalance extremes ar...
The "Good News" Is Always The Same: The Stock Market Is Up... Until It Isn't Authored by Charles Hugh Smith via OfTwoMinds blog, Cloaking a fake "market" with artifice to maintain its asymmetrical distribution of wealth and income also cloaks its detachment from the real world. I often refer to the dynamics of self-correction and self-liquidation. Systems that use feedback to rebalance extremes are self-correcting: rather than accelerate as they approach a cliff, they slow down and reorganize to avoid runaway self-reinforcing feedback (i.e. positive feedback), a.k.a. run to failure . Some things are self-liquidating by design. A mortgage, for example, is intended to be self-liquidating: the monthly payments reduce and eventually extinguish the debt. Other systems become self-liquidating when artifice becomes the "solution" for those seeking to lock the system down to maintain their share of the spoils. This is the inevitable consequence when a culture veers into the black-hole spiral of moral decay , where integrity is dissolved by maximizing self-interest by any means available . Responding to real-world feedback threatens to reduce insiders' share of the spoils, and to make sure this doesn't happen, insiders steer the system away from the real world, creating an artificial, synthetic representation of the system that relies not on real-world feedback but on signals and symbolism that can be engineered to serve the interests of those holding the levers of power and influence. To those benefiting from a system, corrective feedback is anathema because it reduces their share of the spoils. The "solution" is various forms of artifice that maintain the illusion that the system is stable and responsive to the interests of all, when in fact it's been locked in a configuration that benefits the few at the expense of the many. Self-serving artifice comes in many forms: the gaming of statistics to put lipstick on the real-world pig, the TACO Trade--announce some fabrication ...